Foresite Capital Management VI LLC logo

Foresite Capital Management VI LLC Portfolio Analytics

Investment Analysis & Holdings Breakdown

Comprehensive portfolio analytics for Foresite Capital Management VI LLC with $258.9M in long positions as of Q3 2025, 79% allocated to Healthcare, and 99% concentrated in top 10 positions.

Portfolio Value
$258.9M
Top 10 Concentration
99%
Top Sector
Healthcare (79%)
US Exposure
100%
Market Cap Focus
Mid Cap
Countries
1

Composition Analysis

Portfolio breakdown by sector, industry, and market capitalization

Sector Allocation

Healthcare: 78.60%Healthcare
Healthcare
78.60%

Industry Breakdown

1 industry across all sectors

Biotechnology: 78.58%Biotechnology
Biotechnology
Healthcare
78.58%

Filter by Sector

Select a sector to filter industries

Market Cap Distribution

Mid Cap ($2B - $10B): 51.10%Mid Cap ($2B - $10B)Small Cap ($300M - $2B): 35.96%Small Cap ($300M - $2B)Nano Cap (< $50M): 0.63%N/A (ETF or Unknown): 12.31%N/A (ETF or Unknown)
Mid Cap ($2B - $10B)
51.10%
Small Cap ($300M - $2B)
35.96%
Nano Cap (< $50M)
0.63%
N/A (ETF or Unknown)
12.31%

Portfolio Concentration

Top 10 Holdings %
98.7%
Top 20 Holdings %
100.0%
Top 50 Holdings %
100.0%
Top 100 Holdings %
100.0%

Geographic Exposure

Portfolio breakdown by country of incorporation

Domestic (US)
100.0%
International
-
Countries
1
United States of America
100.00% ($258.9M)
12 holdings

Holding Behavior

Investment patterns and position management analysis

Portfolio Stability & Commitment

Avg. Top 10
2.3 quarters
Avg. Top 20
2.3 quarters
Avg. All Positions
2.3 quarters
Median Holding Period
3 quarters
Persistence Rate
-
Persistent Holdings Weight
-
Persistent Positions
0
Longest Held
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 3 quarters

Position Sizing & Influence

Current Quarter

Avg. New Position
5.61%
Avg. Position Weight
8.33%
Largest Position
CG Oncology, Inc. Common stock logo
CG Oncology, Inc. Common stockCGON - 34.57%
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 9.45%
Avg. Ownership Stake
3.34%
Ownership Stake >5%
2
Ownership Stake >1%
6

Historical (Since Q4 2024)

Avg. New Position
5.63%
Avg. Ownership Stake
3.71%
Largest Position
CG Oncology, Inc. Common stock logo
CG Oncology, Inc. Common stockCGON - 34.57% (Q3 2025)
Largest Ownership Stake
RAPT Therapeutics, Inc. Common Stock logo
RAPT Therapeutics, Inc. Common StockRAPT - 35.76% (Q4 2024)

Portfolio Turnover

Current Quarter

Turnover Ratio
12.7%
Value Traded
$32.91M
Positions Added
1
Positions Exited
9

Historical (Since Q4 2024)

Avg. Turnover Ratio
18.2%
Avg. Positions Added
5
Avg. Positions Exited
2
Highest Turnover
50.0%
Q4 2024

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.